8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
Topic archive
oregon
2 stories
8/18/2026
Puerto Rico advances psychedelic therapy research
Governor's order initiates ibogaine, MDMA, and psilocybin study